Company name: Redecan Pharm
Description: Developer of medical marijuana products. The company offers medical marijuana products to cancer patients, people with spinal injuries and depression.
Year founded: 2014
Industry: Consumer Products and Services (B2C) | Group: Consumer Non-Durables | Code:
Start up capital raised (USD Million):
Business status: Generating Revenue
Ownership: Privately Held (no backing)
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Earnings before interest, tax, depreciation and amortization (EBITDA):
Financing Status: The company reached a definitive agreement to be acquired by Alta Vista Ventures (CNQ: AVV) for CAD 9 million on November 27, 2015. Subsequently the deal was cancelled on March 7, 2016.
Number of active investors:
Profile last updated: 08-Sep-2018
Last known valuation: 7.55
Last known valuation date: 07-Mar-2016